Tarsus Pharmaceuticals (TARS) Prepaid Assets (2019 - 2026)

Tarsus Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $26.7 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 345.37% year-over-year to $26.7 million in Q1 2026; TTM through Mar 2026 was $26.7 million, a 345.37% increase from a year earlier, with the FY2025 full-year figure at $13.5 million, down 8.03% from the prior year.
• Prepaid Assets rose to $26.7 million in Q1 2026 per TARS's latest filing, from $13.5 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $29.2 million in Q2 2025 and bottomed at $3.1 million in Q1 2022.
• The 5-year median for Prepaid Assets is $6.0 million (2023), against an average of $10.0 million.
• Biggest YoY gain for Prepaid Assets was 388.5% in 2025; the steepest drop was 11.82% in 2025.
• Year by year, Prepaid Assets stood at $4.8 million in 2022, then jumped by 65.05% to $7.9 million in 2023, then surged by 86.2% to $14.6 million in 2024, then decreased by 8.03% to $13.5 million in 2025, then surged by 98.31% to $26.7 million in 2026.
• Per Business Quant, the three latest TARS Prepaid Assets figures stand at $26.7 million (Q1 2026), $13.5 million (Q4 2025), and $21.7 million (Q3 2025).